Retina

How data-driven VR/AR is driving new insight into visual impairments.

New immunotherapies have radically changed cancer care – what off-target effects should ophthalmologists look out for?

The promise of genome editing is tempered for genetically heterogeneous diseases – introducing a new approach for rhodopsin-dependent retinitis pigmentosa.

A hand-held device that aims to reduce the disease burden for AMD patients

Could a new image analysis technique contribute to earlier or more accurate diagnosis of AMD?

Ten tips for being a better retina surgeon, after you’ve completed your fellowship.

How Seva plans to add another million sight-saving surgeries in developing countries per year by 2020.

Simpler to produce and easier to administer than stem cell therapies – are exosomes the answer to our retinal regeneration needs?

Reprogramming cells to sidestep disease – or turning back the clock on senescent cells in age-related disease? Here’s what we can do today – and what’s on the horizon.

We need to reinforce the message to stop smoking.